10
Mar

Northwest Biotherapeutics announced that German health regulators have OK’d a special hospital exemption that allows the sale of its controversial–and unproven–dendritic vaccine for brain cancer for all glioma brain cancers.

…read more

Source: Northwest Bio touts a chance to start selling its controversial brain cancer vaccine

    

0 No comments